41 – 50 of 350
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Screening for prostate cancer : evidence, ongoing trials, policies and knowledge gaps
- Contribution to journal › Scientific review
-
Mark
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium
- Contribution to journal › Article
- 2022
-
Mark
Nuclear expression of pSTAT3Tyr705 and pSTAT3Ser727 in the stromal compartment of localized hormone-naïve prostate cancer
- Contribution to journal › Article
-
Mark
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
- Contribution to journal › Article
-
Mark
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
- Contribution to journal › Article
-
Mark
Drug use disorder and risk of incident and fatal prostate cancer among Swedish men : a nationwide epidemiological study
- Contribution to journal › Article
-
Mark
Isolation of Circulating Tumor Cells with Acoustophoresis : Towards a biomarker assay for prostate cancer
(2022)
- Thesis › Doctoral thesis (compilation)
-
Mark
Aspects of PET-CT in prostate cancer. Protocol optimization, diagnostic accuracy, and dosimetry.
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
- Contribution to journal › Article
-
Mark
PSA : role in screening and monitoring patients with prostate cancer
(2022) p.131-172
- Chapter in Book/Report/Conference proceeding › Book chapter
